Why Protean exists
Protean FusionPlus detects gene fusions that can drive cancer, including ALK, ROS1, NTRK, and RET fusions. It is for patients whose tumors may carry these specific mutations and whose care teams want to find out. Identifying a fusion matters because it names the specific change driving the cancer, giving patients and doctors concrete information to weigh in treatment decisions.
- 1
Order the test
The test is ordered through a test requisition form or the ordering portal.
- 2
Specimen retrieval
Specimen retrieval and return of FFPE solid tumor tissue is handled by the company.
- 3
Receive results
Results are returned in about 10 business days.
Prefer the source? Protean FusionPlus's own site has more.
